PURPOSE The CD20 antigen is expressed on more than 90% of B-cell lymphomas. It is
appealing for targeted therapy, because it does not shed or modulate. A chimeric monoclonal …

The prognosis of follicular lymphomas (FL) is heterogeneous and numerous treatments may
be proposed. A validated prognostic index (PI) would help in evaluating and choosing these …

This article summarizes technical advances contained in the fifth major release of the Q-Chem
quantum chemistry program package, covering developments since 2015. A …

This 2001 book offers an examination of functional explanation as it is used in biology and
the social sciences, and focuses on the kinds of philosophical presuppositions that such …

A percutaneous catheter technique for permanent closure of the isolated, persistently patent
ductus arteriosus (PDA) was first described in 1967. The development of a spring-loaded …

PURPOSE: This phase II trial investigated the safety and efficacy of re-treatment with rituximab,
a chimeric anti-CD20 monoclonal antibody, in patients with low-grade or follicular non-…

OBJECTIVES The purpose of this study is to evaluate right ventricular (RV) volume and
function after pulmonary valve replacement (PVR) and to address the issue of optimal surgical …

Purpose The aim of the F2 study was to verify whether a prospective collection of data
would enable the development of a more accurate prognostic index for follicular lymphoma (FL) …

Ninety patients with progressive recurrent lymphoma were treated with a combination of
cisplatin 100 mg/m2 intravenously (IV) by continuous infusion over 24 hours, followed by …

Purpose To determine the response, failure-free survival (FFS), and overall survival rates
and toxicity of rituximab plus an intense chemotherapy regimen in patients with previously …